HiroshiMiyamotoMD

Pathology • Rochester, NY

Anatomic Pathology

Associate Professor of Pathology, Associate Professor of Urology, Johns Hopkins University School of Medicine

Join to view full profile

Are you Dr. Miyamoto?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
601 Elmwood Ave
# 320
Rochester, NY 14642
Phone+1 585-275-8748

Fax+1 585-273-3637

Summary

Dr. Hiroshi Miyamoto, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Maryland. He is affiliated with Strong Memorial Hospital of the University of Rochester and F. F. Thompson Hospital.

Education & Training

Johns Hopkins University School of MedicineSelective Pathology, 2008 - 2009
Yokohama City University School of MedicineClass of 1988

Certifications & Licensure

NY State Medical License 2008 - 2026
MD State Medical License 2013 - 2017
American Board of Pathology Pathology - Anatomic

Publications & Presentations

PubMed

Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma.
Ying Wang, Yuki Teramoto, Hiroshi Miyamoto
Pathology. 2025-02-01
A nationwide multicenter study of the cost effectiveness of five leading drugs for pharmacological management of cervicobrachial symptoms.
Norimitsu Wakao, Takeo Furuya, Toshitaka Yoshii, Hideyuki Arima, Yu Yamato
Journal of Orthopaedic Science. 2025-01-01
TRPS1 is a useful marker in differentiating metastatic breast carcinoma from pancreatic adenocarcinoma in fine-needle aspiration specimens.
Bahadir Yildiz, Jerome Jean-Gilles Jr, Ellen J Giampoli, Sierra Kovar-Peltz, Qi Yang
American Journal of Clinical Pathology. 2024-12-05

Press Mentions

Time-Dependent Efficacy of Combination of Silver-Containing Hydroxyapatite Coating and Vancomycin on Methicillin-Resistant Staphylococcus Aureus Biofilm Formation in VitroMarch 2nd, 2021
Effects of α1-Adrenergic Receptor Antagonists on the Development and Progression of Urothelial CancerDecember 1st, 2020
Enhanced Metastatic Potential in the MB49 Urothelial Carcinoma ModelMay 15th, 2019

Other Languages

Japanese